Review: taking Risperidone and Hydroxyzine hydrochloride together


Summary

Drug interactions are reported among people who take Risperidone and Hydroxyzine hydrochloride together. This review analyzes the effectiveness and drug interactions between Risperidone and Hydroxyzine hydrochloride. It is created by eHealthMe based on reports of 1,290 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Risperidone

Risperidone has active ingredients of risperidone. It is often used in schizophrenia. (latest outcomes from Risperidone 23,149 users)

Hydroxyzine Hydrochloride

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine hydrochloride 1,770 users)

On Sep, 17, 2016

1,290 people who take Risperidone, Hydroxyzine Hydrochloride are studied.


Number of reports submitted per year:

Risperidone and Hydroxyzine hydrochloride drug interactions.

Drug effectiveness over time:

Risperidone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Hydrochloride:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 12.0% - (1 of 8 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Risperidone:
  • female: 33.0% - (2 of 6 people)
  • male: 33.0% - (2 of 6 people)
Hydroxyzine Hydrochloride:
  • female: 28.0% - (2 of 7 people)
  • male: 16.0% - (1 of 6 people)

Drug effectiveness by age:

Risperidone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 60.0% - (3 of 5 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Hydroxyzine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 40.0% - (2 of 5 people)
  • 20-29: 33.0% - (1 of 3 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • drug rash with eosinophilia and systemic symptoms
  • somnolence
  • white blood cell count decreased
  • cerebral infarction
  • cytomegalovirus infection
  • calciphylaxis
  • pyrexia
  • hypokalaemia
  • tachycardia
  • agitation
1 - 6 months:
  • hypokalaemia
  • diabetes mellitus
  • weight increased
  • torsade de pointes
  • type 2 diabetes mellitus
  • ventricular tachycardia
  • fall
  • diabetic ketoacidosis
  • pneumonia
  • blood cholesterol increased
6 - 12 months:
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • cardiac arrest
  • diabetes mellitus
  • electrocardiogram qt prolonged
  • diabetic ketoacidosis
  • diabetic neuropathy
  • back pain
  • hyperlipidaemia
  • blood triglycerides increased
1 - 2 years:
  • type 2 diabetes mellitus
  • cardiac arrest
  • electrocardiogram qt prolonged
  • weight increased
  • diabetes mellitus
  • abdominal pain upper
  • hyperglycaemia
  • blood cholesterol increased
  • paranoia
  • type 1 diabetes mellitus
2 - 5 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • hyperlipidaemia
  • blood cholesterol increased
  • blood triglycerides increased
  • nervous system disorder
  • neuropathy peripheral
  • cerebrovascular accident
  • dyskinesia
5 - 10 years:
  • type 2 diabetes mellitus
  • polydipsia
  • polyuria
  • gynaecomastia
  • obesity
  • abnormal weight gain
  • cellulitis
  • central nervous system lesion
  • diabetic neuropathy
  • mental disorder
10+ years:
  • obesity
  • gynaecomastia
  • blood cholesterol increased
  • diabetes mellitus
  • emotional distress
  • hyperglycaemia
  • hyperlipidaemia
  • type 2 diabetes mellitus
  • adverse drug reaction
  • arthralgia
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • back pain
  • insomnia
  • anxiety
  • dyspnoea
  • weight increased
  • nausea
  • suicidal ideation

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • back pain
  • weight increased
  • nausea
  • dyspnoea
  • headache
  • insomnia
  • anxiety
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • tachycardia
  • dehydration
  • somnolence
  • weight increased
  • aggression
  • cytolytic hepatitis
  • agitation
  • rhabdomyolysis

Most common drug interactions by age *:

0-1:
  • foetal exposure during pregnancy
  • hypotonia
  • maternal drugs affecting foetus
  • somnolence
  • apathy
  • apgar score low
  • asthenia
  • back pain
  • bradycardia neonatal
  • calculus ureteric
2-9:
  • agitation
  • aggression
  • dehydration
  • dyskinesia
  • hyperthermia
  • rhabdomyolysis
  • tachycardia
  • altered state of consciousness
  • cytolytic hepatitis
  • renal failure acute
10-19:
  • drug rash with eosinophilia and systemic symptoms
  • pyrexia
  • somnolence
  • tachycardia
  • abdominal pain
  • alanine aminotransferase increased
  • tremor
  • constipation
  • aspartate aminotransferase increased
  • bronchopulmonary aspergillosis
20-29:
  • weight increased
  • diabetes mellitus
  • back pain
  • suicidal ideation
  • abdominal pain upper
  • neck pain
  • vision blurred
  • sleep apnoea syndrome
  • asthenia
  • drug abuse
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • arthralgia
  • anxiety
  • hypertension
  • headache
  • migraine
  • blood cholesterol increased
  • diabetic ketoacidosis
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • back pain
  • hypokalaemia
  • chest pain
  • nausea
  • insomnia
  • depression
  • weight increased
  • suicidal ideation
50-59:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • weight increased
  • head injury
  • fall
  • gastrooesophageal reflux disease
  • completed suicide
  • pyrexia
  • neuropathy peripheral
60+:
  • fall
  • confusional state
  • hypotension
  • malaise
  • renal failure
  • electrocardiogram qt prolonged
  • cardiac arrest
  • somnolence
  • dehydration
  • neuroleptic malignant syndrome

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Risperidone and Hydroxyzine hydrochloride?

Can you answer these questions?

More questions for: Risperidone, Hydroxyzine hydrochloride

You may be interested in these reviews

More reviews for: Risperidone, Hydroxyzine hydrochloride

On eHealthMe, Risperidone (risperidone) is often used to treat schizophrenia. Hydroxyzine hydrochloride (hydroxyzine hydrochloride) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.